Biogen Net Income 2006-2021 | BIIB

Biogen annual/quarterly net income history and growth rate from 2006 to 2021. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Biogen net income for the quarter ending March 31, 2021 was $0.410B, a 70.68% decline year-over-year.
  • Biogen net income for the twelve months ending March 31, 2021 was $3.012B, a 48.77% decline year-over-year.
  • Biogen annual net income for 2020 was $4.001B, a 32.06% decline from 2019.
  • Biogen annual net income for 2019 was $5.889B, a 32.9% increase from 2018.
  • Biogen annual net income for 2018 was $4.431B, a 74.5% increase from 2017.
Biogen Annual Net Income
(Millions of US $)
2020 $4,001
2019 $5,889
2018 $4,431
2017 $2,539
2016 $3,703
2015 $3,547
2014 $2,935
2013 $1,862
2012 $1,380
2011 $1,234
2010 $1,005
2009 $970
2008 $783
2007 $638
2006 $218
2005 $161
Biogen Quarterly Net Income
(Millions of US $)
2021-03-31 $410
2020-12-31 $358
2020-09-30 $702
2020-06-30 $1,542
2020-03-31 $1,399
2019-12-31 $1,440
2019-09-30 $1,546
2019-06-30 $1,494
2019-03-31 $1,409
2018-12-31 $947
2018-09-30 $1,444
2018-06-30 $867
2018-03-31 $1,173
2017-12-31 $-297
2017-09-30 $1,226
2017-06-30 $863
2017-03-31 $748
2016-12-31 $649
2016-09-30 $1,033
2016-06-30 $1,050
2016-03-31 $971
2015-12-31 $832
2015-09-30 $966
2015-06-30 $927
2015-03-31 $823
2014-12-31 $883
2014-09-30 $857
2014-06-30 $715
2014-03-31 $480
2013-12-31 $457
2013-09-30 $488
2013-06-30 $491
2013-03-31 $427
2012-12-31 $292
2012-09-30 $398
2012-06-30 $387
2012-03-31 $303
2011-12-31 $300
2011-09-30 $352
2011-06-30 $288
2011-03-31 $294
2010-12-31 $240
2010-09-30 $254
2010-06-30 $293
2010-03-31 $217
2009-12-31 $306
2009-09-30 $278
2009-06-30 $143
2009-03-31 $244
2008-12-31 $207
2008-09-30 $207
2008-06-30 $207
2008-03-31 $163
2007-12-31 $201
2007-09-30 $119
2007-06-30 $186
2007-03-31 $132
2006-12-31 $109
2006-09-30 $157
2006-06-30 $-171
2006-03-31 $123
2005-12-31 $56
2005-09-30 $27
2005-06-30 $35
2005-03-31 $43
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $62.437B $13.445B
Biogen is a leading biopharmaceutical company engaged in the research, development and marketing of targeted therapies for the treatment of cancer, autoimmune and inflammatory diseases. The company owns industry leading brands for the treatment of multiple sclerosis, next-generation treatments for hemophilia, and a deep clinical pipeline ranging from Alzheimer's disease, lupus nephritis to neuropathic pain.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $150.471B 10.43
Amgen (AMGN) United States $140.559B 15.17
CSL (CSLLY) Australia $104.678B 0.00
Moderna (MRNA) United States $87.132B 173.60
Gilead Sciences (GILD) United States $86.902B 9.25
Illumina (ILMN) United States $65.798B 94.88
BioNTech SE (BNTX) Germany $57.922B 42.00
Regeneron Pharmaceuticals (REGN) United States $56.686B 16.23
Vertex Pharmaceuticals (VRTX) United States $56.114B 23.11
Alexion Pharmaceuticals (ALXN) United States $40.223B 15.28
BeiGene (BGNE) Cayman Islands $32.408B 0.00
Seagen (SGEN) United States $28.760B 49.68
Genmab (GMAB) Denmark $28.630B 33.56
Genmab (GNMSF) Denmark $25.912B 5.96
Horizon Therapeutics Public (HZNP) Ireland $21.117B 27.00
Exact Sciences (EXAS) United States $20.914B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $20.582B 0.00
CureVac (CVAC) Germany $19.775B 0.00
Incyte (INCY) United States $19.250B 38.06
Alnylam Pharmaceuticals (ALNY) United States $19.190B 0.00
Bio-Rad Laboratories (BIO.B) United States $17.251B 41.91
Bio-Techne Corp (TECH) United States $16.949B 89.12
Zai Lab (ZLAB) China $16.404B 0.00
ARGENX SE-ADR (ARGX) Netherlands $15.848B 0.00
BioMarin Pharmaceutical (BMRN) United States $15.290B 139.45
Novavax (NVAX) United States $15.185B 0.00
Guardant Health (GH) United States $12.184B 0.00
QIAGEN (QGEN) Netherlands $10.879B 19.32
Repligen (RGEN) United States $10.432B 94.06
CRISPR Therapeutics AG (CRSP) Switzerland $9.373B 0.00
Denali Therapeutics (DNLI) United States $8.994B 322.65
Mirati Therapeutics (MRTX) United States $8.728B 0.00
Fate Therapeutics (FATE) United States $8.315B 0.00
Acceleron Pharma (XLRN) United States $7.944B 0.00
Exelixis (EXEL) United States $7.192B 114.75
Sarepta Therapeutics (SRPT) United States $6.920B 0.00
Ascendis Pharma (ASND) Denmark $6.902B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $6.733B 0.00
AbCellera Biologics (ABCL) $6.730B 0.00
Ultragenyx Pharmaceutical (RARE) United States $6.705B 0.00
Vir Biotechnology (VIR) United States $6.038B 0.00
Halozyme Therapeutics (HALO) United States $5.940B 32.59
SWEDISH ORP BIO (BIOVF) Sweden $5.677B 20.57
Intellia Therapeutics (NTLA) United States $5.667B 0.00
Beam Therapeutics (BEAM) United States $5.501B 0.00
Legend Biotech (LEGN) United States $5.465B 0.00
Twist Bioscience (TWST) United States $5.460B 0.00
Adaptive Biotechnologies (ADPT) United States $5.321B 0.00
I-Mab (IMAB) China $5.309B 0.00
Reata Pharmaceuticals (RETA) United States $5.297B 0.00
Galapagos (GLPG) Belgium $5.285B 0.00
NeoGenomics (NEO) United States $5.056B 857.40
Blueprint Medicines (BPMC) United States $4.907B 14.94
Apellis Pharmaceuticals (APLS) United States $4.903B 0.00
ACADIA Pharmaceuticals (ACAD) United States $4.373B 0.00
Certara (CERT) United States $4.155B 0.00
SpringWorks Therapeutics (SWTX) United States $4.120B 0.00
Arvinas (ARVN) United States $4.055B 0.00
Alkermes (ALKS) Ireland $4.035B 0.00
Arena Pharmaceuticals (ARNA) United States $3.925B 0.00
Intra-Cellular Therapies (ITCI) United States $3.518B 0.00
Emergent Biosolutions (EBS) United States $3.509B 6.99
Berkeley Lights (BLI) United States $3.155B 0.00
Insmed (INSM) United States $3.009B 0.00
Amicus Therapeutics (FOLD) United States $2.850B 0.00
MorphoSys AG (MOR) Germany $2.830B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $2.815B 0.00
Vericel (VCEL) United States $2.673B 720.75
Global Blood Therapeutics (GBT) United States $2.595B 0.00
Dicerna Pharmaceuticals (DRNA) United States $2.581B 0.00
Sorrento Therapeutics (SRNE) United States $2.509B 0.00
Editas Medicine (EDIT) United States $2.503B 0.00
ALX Oncology Holdings (ALXO) United States $2.455B 0.00
Kymera Therapeutics (KYMR) United States $2.339B 0.00
Bluebird Bio (BLUE) United States $2.286B 0.00
Myriad Genetics (MYGN) United States $2.258B 0.00
Myovant Sciences (MYOV) United Kingdom $2.184B 0.00
Morphic Holding (MORF) United States $2.176B 0.00
Instil Bio (TIL) United States $2.156B 0.00
Heska (HSKA) United States $2.148B 936.59
Revance Therapeutics (RVNC) United States $2.133B 0.00
Bionano Genomics (BNGO) United States $2.130B 0.00
Atea Pharmaceuticals (AVIR) United States $2.075B 0.00
Seer (SEER) $2.071B 0.00
Ligand Pharmaceuticals (LGND) United States $2.012B 33.66
Deciphera Pharmaceuticals (DCPH) United States $1.986B 0.00
Prothena (PRTA) Ireland $1.967B 0.00
Amarin (AMRN) Ireland $1.926B 0.00
Inovio Pharmaceuticals (INO) United States $1.916B 0.00
Seres Therapeutics (MCRB) United States $1.878B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.857B 0.00
C4 Therapeutics (CCCC) United States $1.814B 0.00
Castle Biosciences (CSTL) United States $1.785B 0.00
Arcus Biosciences (RCUS) United States $1.766B 0.00
Zymeworks (ZYME) Canada $1.735B 0.00
Genetron Holdings (GTH) China $1.719B 0.00
BioAtla (BCAB) United States $1.717B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.714B 0.00
Sangamo Therapeutics (SGMO) United States $1.692B 0.00
UniQure (QURE) Netherlands $1.687B 0.00
PureTech Health (PRTC) United States $1.651B 0.00
PHARMA MAR SA (PHMMF) Spain $1.635B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.635B 0.00
REGENXBIO (RGNX) United States $1.606B 0.00
Alector (ALEC) United States $1.548B 0.00
Cytokinetics (CYTK) United States $1.544B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.531B 0.00
Protagonist Therapeutics (PTGX) United States $1.487B 0.00
Precigen (PGEN) United States $1.443B 0.00
Codexis (CDXS) United States $1.410B 0.00
NGM Biopharmaceuticals (NGM) United States $1.396B 0.00
Zealand Pharma (ZEAL) Denmark $1.383B 0.00
Avid Bioservices (CDMO) United States $1.381B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.329B 0.00
Northwest Biotherapeutics (NWBO) United States $1.327B 0.00
Ocugen (OCGN) United States $1.326B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.312B 0.00
Nurix Therapeutics (NRIX) United States $1.296B 0.00
Repare Therapeutics (RPTX) Canada $1.254B 0.00
KaloBios Pharmaceuticals (HGEN) United States $1.245B 0.00
Keros Therapeutics (KROS) United States $1.224B 0.00
Shattuck Labs (STTK) United States $1.213B 0.00
Celldex Therapeutics (CLDX) United States $1.211B 0.00
MiMedx (MDXG) United States $1.204B 0.00
Zealand Pharma (ZLDPF) Denmark $1.167B 0.00
Curis (CRIS) United States $1.161B 0.00
Agenus (AGEN) United States $1.141B 0.00
Pliant Therapeutics (PLRX) United States $1.134B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.067B 33.70
Dynavax Technologies (DVAX) United States $1.065B 0.00
Coherus BioSciences (CHRS) United States $1.062B 0.00
VBI Vaccines (VBIV) United States $1.045B 0.00
Mersana Therapeutics (MRSN) United States $1.043B 0.00
Mesoblast (MESO) Australia $1.034B 0.00
Scholar Rock Holding (SRRK) United States $1.022B 0.00
MannKind (MNKD) United States $1.004B 0.00
Avidity Biosciences (RNA) United States $0.950B 0.00
G1 THERAPEUTICS (GTHX) United States $0.922B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.917B 0.00
Cel-Sci (CVM) United States $0.911B 0.00
Merus (MRUS) Netherlands $0.907B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.894B 0.00
Inhibrx (INBX) United States $0.893B 0.00
Travere Therapeutics (TVTX) United States $0.883B 0.00
Sutro Biopharma (STRO) United States $0.867B 0.00
Epizyme (EPZM) United States $0.865B 0.00
Prometheus Biosciences (RXDX) United States $0.826B 0.00
Nkarta (NKTX) United States $0.826B 0.00
Affimed (AFMD) Germany $0.806B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.778B 0.00
Pharming Group (PHAR) Netherlands $0.771B 0.00
Verastem (VSTM) United States $0.756B 0.00
Pharming Group (PHGUF) Netherlands $0.751B 20.00
SESEN BIO, INC (SESN) United States $0.724B 0.00
Kadmon Holdings (KDMN) United States $0.724B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.723B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.713B 0.00
IDEAYA Biosciences (IDYA) United States $0.713B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.711B 0.00
Clene (CLNN) United States $0.706B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.699B 0.00
Cellectis S.A (CLLS) France $0.696B 0.00
Cara Therapeutics (CARA) United States $0.694B 60.26
ChromaDex (CDXC) United States $0.681B 0.00
Precision BioSciences (DTIL) United States $0.675B 0.00
AnaptysBio (ANAB) United States $0.668B 0.00
MeiraGTx Holdings (MGTX) United States $0.659B 0.00
DBV Technologies S.A (DBVT) France $0.655B 0.00
Anika Therapeutics (ANIK) United States $0.644B 0.00
Sinovac Biotech (SVA) China $0.642B 6.47
Orchard Therapeutics (ORTX) United Kingdom $0.641B 0.00
Brooklyn ImmunoTherapeutics (BTX) United States $0.630B 0.00
ALBIREO PHARMA (ALBO) United States $0.627B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.625B 0.00
Clovis Oncology (CLVS) United States $0.624B 0.00
Bolt Biotherapeutics (BOLT) United States $0.605B 0.00
Adagene (ADAG) China $0.598B 0.00
Codiak BioSciences (CDAK) United States $0.590B 0.00
Compugen (CGEN) Israel $0.571B 0.00
Inventiva S.A (IVA) France $0.566B 0.00
Selecta Biosciences (SELB) United States $0.561B 0.00
Forte Biosciences (FBRX) United States $0.554B 0.00
AC Immune SA (ACIU) Switzerland $0.524B 0.00
Starpharma Holdings (SPHRY) Australia $0.519B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.517B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.513B 0.00
XBiotech (XBIT) United States $0.512B 0.00
Gritstone Bio (GRTS) United States $0.502B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.494B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.483B 0.00
Geron (GERN) United States $0.475B 0.00
Athenex (ATNX) United States $0.472B 0.00
CytomX Therapeutics (CTMX) United States $0.469B 0.00
Spero Therapeutics (SPRO) United States $0.468B 0.00
RAPT THERAPTICS (RAPT) United States $0.467B 0.00
Puma Biotechnology (PBYI) United States $0.460B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.456B 0.00
Neoleukin Therapeutics (NLTX) United States $0.450B 0.00
Oncobiologics (OTLK) United States $0.446B 0.00
BeyondSpring (BYSI) United States $0.445B 0.00
AquaBounty Technologies (AQB) United States $0.440B 0.00
ANI Pharmaceuticals (ANIP) United States $0.435B 12.02
Cue Biopharma (CUE) United States $0.423B 0.00
Amryt Pharma (AMYT) United Kingdom $0.421B 0.00
Fortress Biotech (FBIO) United States $0.418B 0.00
Kala Pharmaceuticals (KALA) United States $0.412B 0.00
Angion Biomedica (ANGN) United States $0.403B 0.00
Opthea (OPT) Australia $0.389B 0.00
Adicet Bio (ACET) United States $0.379B 0.00
SQZ Biotechnologies (SQZ) United States $0.376B 0.00
WAVE Life Sciences (WVE) Singapore $0.372B 0.00
Syros Pharmaceuticals (SYRS) United States $0.364B 0.00
UROGEN PHARMA (URGN) United States $0.362B 0.00
BioDelivery Sciences (BDSI) United States $0.362B 14.68
Athersys (ATHX) United States $0.360B 0.00
Adverum Biotechnologies (ADVM) United States $0.358B 0.00
XOMA (XOMA) United States $0.345B 161.10
IBio (IBIO) United States $0.344B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.341B 0.00
Prima BioMed (IMMP) Australia $0.339B 0.00
Cerecor (CERC) United States $0.338B 0.00
Trevena (TRVN) United States $0.334B 0.00
Theratechnologies (THTX) Canada $0.333B 0.00
Frequency Therapeutics (FREQ) United States $0.331B 0.00
Innate Pharma S.A (IPHA) France $0.326B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.321B 0.00
Arbutus Biopharma (ABUS) United States $0.320B 0.00
Kaleido Biosciences (KLDO) $0.314B 0.00
CorMedix Inc (CRMD) United States $0.309B 0.00
Cogent Biosciences (COGT) United States $0.307B 0.00
OVID THERAPEUTC (OVID) United States $0.302B 2.97
Cardiff Oncology (CRDF) United States $0.300B 0.00
Kindred Biosciences (KIN) United States $0.299B 0.00
Fulcrum Therapeutics (FULC) United States $0.295B 0.00
PDL BioPharma (PDLI) United States $0.283B 0.00
Bellus Health (BLU) Canada $0.274B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.274B 0.00
Talis Biomedical (TLIS) United States $0.266B 0.00
Kamada (KMDA) Israel $0.265B 18.03
Seelos Therapeutics (SEEL) United States $0.262B 0.00
HOOKIPA Pharma (HOOK) United States $0.261B 0.00
INmune Bio (INMB) United States $0.256B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.248B 0.00
Chiasma (CHMA) United States $0.241B 0.00
Checkpoint Therapeutics (CKPT) United States $0.240B 0.00
ADMA Biologics Inc (ADMA) United States $0.237B 0.00
NextCure (NXTC) United States $0.231B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.227B 0.00
X4 Pharmaceuticals (XFOR) United States $0.223B 0.00
Aptinyx (APTX) United States $0.219B 0.00
VTv Therapeutics (VTVT) United States $0.217B 0.00
OSMOTICA PHARM (OSMT) United States $0.201B 0.00
POXEL SA FRANCE (PXXLF) France $0.197B 0.00
Biofrontera AG (BFRA) Germany $0.195B 0.00
Strongbridge Biopharma (SBBP) United States $0.193B 0.00
Synlogic (SYBX) United States $0.192B 0.00
TELA Bio (TELA) United States $0.192B 0.00
GENFIT S.A (GNFT) France $0.190B 0.00
VolitionRX (VNRX) United States $0.189B 0.00
Abeona Therapeutics (ABEO) United States $0.183B 0.00
Voyager Therapeutics (VYGR) United States $0.183B 4.70
Applied Genetic Technologies (AGTC) United States $0.183B 0.00
ObsEva SA (OBSV) Switzerland $0.181B 0.00
Clearside Biomedical (CLSD) United States $0.179B 0.00
Nicox SA (NICXF) France $0.171B 0.00
PHASEBIO PHARMA (PHAS) United States $0.170B 0.00
Galena Biopharma (SLS) United States $0.170B 0.00
Antibe Therapeutics (ATBPF) Canada $0.164B 0.00
Enzo Biochem (ENZ) United States $0.164B 48.57
Yumanity Therapeutics (YMTX) United States $0.162B 0.00
Eton Pharmaceuticals (ETON) United States $0.157B 0.00
LogicBio Therapeutics (LOGC) United States $0.156B 0.00
DiaMedica Therapeutics (DMAC) United States $0.156B 0.00
Exicure (XCUR) United States $0.153B 0.00
Liminal BioSciences (LMNL) Canada $0.144B 0.00
Catalyst Biosciences (CBIO) United States $0.143B 0.00
Liquidia Technologies (LQDA) United States $0.143B 0.00
Cyclerion Therapeutics (CYCN) United States $0.142B 0.00
Palatin Technologies (PTN) United States $0.141B 0.00
Eyenovia (EYEN) United States $0.140B 0.00
Pluristem Therapeutics (PSTI) Israel $0.137B 0.00
Orgenesis (ORGS) United States $0.136B 278.50
ANIXA BIOSCIENCES INC (ANIX) United States $0.136B 0.00
Erytech Pharma SA (ERYP) France $0.136B 0.00
Novogen (KZIA) Australia $0.134B 0.00
F-star Therapeutics (FSTX) United Kingdom $0.134B 0.00
Aytu BioPharma (AYTU) United States $0.134B 0.00
ABVC BioPharma (ABVC) United States $0.128B 0.00
Longeveron (LGVN) United States $0.126B 0.00
Vascular Biogenics (VBLT) Israel $0.123B 0.00
Cocrystal Pharma (COCP) United States $0.121B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.117B 0.00
Aptevo Therapeutics (APVO) United States $0.114B 0.00
CytRx (CYTR) United States $0.113B 0.00
Celsion (CLSN) United States $0.113B 0.00
Vyant Bio (VYNT) United States $0.110B 0.00
ARAVIVE, INC (ARAV) United States $0.108B 0.00
Evofem Biosciences (EVFM) United States $0.108B 0.00
Beyond Air (XAIR) United States $0.108B 0.00
Armata Pharmaceuticals (ARMP) United States $0.106B 0.00
Leap Therapeutics (LPTX) United States $0.104B 0.00
Dyadic (DYAI) United States $0.103B 0.00
Cidara Therapeutics (CDTX) United States $0.103B 0.00
TRACON Pharmaceuticals (TCON) United States $0.102B 0.00
Zosano Pharma (ZSAN) United States $0.099B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.097B 0.00
AIkido Pharma (AIKI) United States $0.096B 0.00
Protalix BioTherapeutics (PLX) Israel $0.095B 0.00
Evogene (EVGN) Israel $0.095B 0.00
Lumos Pharma (LUMO) United States $0.093B 0.00
Stealth BioTherapeutics (MITO) Cayman Islands $0.092B 0.00
Purple Biotech (PPBT) Israel $0.089B 0.00
Entera Bio (ENTX) Israel $0.089B 0.00
Celyad SA (CYAD) Belgium $0.085B 0.00
Cleveland BioLabs (CBLI) United States $0.085B 0.00
ARIDIS PHARMACT (ARDS) United States $0.079B 0.00
Emmaus Life Sciences (EMMA) United States $0.078B 0.00
Adocia (ADOCY) France $0.077B 0.00
Edesa Biotech (EDSA) Canada $0.077B 0.00
ATyr Pharma (LIFE) United States $0.077B 0.00
BioCardia (BCDA) United States $0.074B 0.00
Vaccinex (VCNX) United States $0.073B 0.00
Advaxis (ADXS) United States $0.072B 0.00
Alimera Sciences (ALIM) United States $0.072B 0.00
Idera Pharmaceuticals (IDRA) United States $0.065B 0.00
Cyclo Therapeutics (CYTH) United States $0.064B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.064B 0.00
AEterna Zentaris (AEZS) United States $0.064B 0.00
Viridian Therapeutics (VRDN) United States $0.063B 0.00
Genetic Technologies (GENE) Australia $0.063B 0.00
Windtree Therapeutics (WINT) United States $0.062B 0.00
Organovo Holdings (ONVO) United States $0.062B 0.00
Pulmatrix (PULM) United States $0.059B 0.00
AnPac Bio-Medical Science (ANPC) China $0.054B 0.00
Enveric Biosciences (ENVB) United States $0.052B 0.00
Invo BioScience (INVO) United States $0.050B 0.00
Soligenix (SNGX) United States $0.049B 0.00
Timber Pharmaceuticals (TMBR) United States $0.047B 0.00
Happiness Biotech Group (HAPP) China $0.044B 0.00
Benitec Biopharma (BNTC) United States $0.038B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.037B 0.00
Acorda Therapeutics (ACOR) United States $0.036B 0.87
GeoVax Labs (GOVX) United States $0.034B 0.00
ThermoGenesis Holdings (THMO) United States $0.034B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.033B 0.00
Vallon Pharmaceuticals (VLON) United States $0.033B 0.00
Lexaria Bioscience (LEXX) Canada $0.033B 0.00
Prana Biotechnology (ATHE) Australia $0.032B 0.00
ZIVO Bioscience (ZIVO) United States $0.028B 0.00
IMMURON (IMRN) Australia $0.028B 0.00
Titan Pharmaceuticals (TTNP) United States $0.025B 0.00
Palisade Bio (PALI) United States $0.011B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.000B 0.00
ImmunityBio (IBRX) United States $0.000B 0.00
Immatics (IMTX) United States $0.000B 0.00